{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:32:34Z","timestamp":1777984354664,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/00471"],"award-info":[{"award-number":["PI16\/00471"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/00625"],"award-info":[{"award-number":["PI15\/00625"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/00232"],"award-info":[{"award-number":["PI17\/00232"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["201602.30.31"],"award-info":[{"award-number":["201602.30.31"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["201602.30.31"],"award-info":[{"award-number":["201602.30.31"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03105-3","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:03:53Z","timestamp":1772802233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of glycemic optimization on myocardial steatosis and cardiac remodeling in patients with newly diagnosed type 2 diabetes: a longitudinal study"],"prefix":"10.1186","volume":"25","author":[{"given":"\u00c1ngel","family":"Rosales-Rojas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Teis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Gil-Millan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Rossell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Pedraz-Petrozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Vilades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luis","family":"Sanchez-Quesada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvaro","family":"Garc\u00eda-Osuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00eddac","family":"Mauricio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Julve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"issue":"7258","key":"3105_CR1","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton IM. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405\u201312.","journal-title":"BMJ"},{"issue":"1","key":"3105_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-2-1","volume":"2","author":"C Bauters","year":"2003","unstructured":"Bauters C, Lamblin N, Mc Fadden EP, Van Belle E, Millaire A, de Groote P. Influence of diabetes mellitus on heart failure risk and outcome. Cardiovasc Diabetol. 2003;2(1):1.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"3105_CR3","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2015.216","volume":"12","author":"G Jia","year":"2016","unstructured":"Jia G, DeMarco VG, Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 2016;12(3):144\u201353.","journal-title":"Nat Rev Endocrinol"},{"key":"3105_CR4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s00125-023-06068-2","volume":"67","author":"AG Hoek","year":"2024","unstructured":"Hoek AG, Dal Canto E, Wenker E, Bindraban N, Louis Handoko \u00b7 M, Elders PJM, et al. Epidemiology of heart failure in diabetes: a disease in disguise. Diabetologia. 2024;67:574\u2013601.","journal-title":"Diabetologia"},{"issue":"7","key":"3105_CR5","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.amjcard.2003.12.026","volume":"93","author":"JK Boyer","year":"2004","unstructured":"Boyer JK, Thanigaraj S, Schechtman KB, P\u00e9rez JE. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol. 2004;93(7):870\u20135.","journal-title":"Am J Cardiol"},{"issue":"10","key":"3105_CR6","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1161\/CIRCULATIONAHA.106.645614","volume":"116","author":"JM McGavock","year":"2007","unstructured":"McGavock JM, Lingvay I, Zib I, Tillery T, Salas N, Unger R, et al. Cardiac steatosis in diabetes mellitus. Circulation. 2007;116(10):1170\u20135.","journal-title":"Circulation"},{"issue":"22","key":"3105_CR7","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.jacc.2008.07.062","volume":"52","author":"LJ Rijzewijk","year":"2008","unstructured":"Rijzewijk LJ, van der Meer RW, Smit JWA, Diamant M, Bax JJ, Hammer S, et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol. 2008;52(22):1793\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3105_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12933-020-01044-1","volume":"19","author":"Y Gao","year":"2020","unstructured":"Gao Y, Ren Y, Guo Y, kun, Liu X, Xie L jun, Jiang L, et al. Metabolic syndrome and myocardium steatosis in subclinical type 2 diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Cardiovasc Diabetol. 2020;19(1):70.","journal-title":"Cardiovasc Diabetol"},{"issue":"24","key":"3105_CR9","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1161\/CIRCULATIONAHA.110.955542","volume":"122","author":"ACT Ng","year":"2010","unstructured":"Ng ACT, Delgado V, Bertini M, van der Meer RW, Rijzewijk LJ, Hooi Ewe S, et al. Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus. Circulation. 2010;122(24):2538\u201344.","journal-title":"Circulation"},{"issue":"3","key":"3105_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/ejhf.1617","volume":"22","author":"C Wu","year":"2020","unstructured":"Wu C, Lee J, Hsu J, Su MM, Wu Y, Lin T, et al. Myocardial adipose deposition and the development of heart failure with preserved ejection fraction. Eur J Heart Fail. 2020;22(3):445\u201354.","journal-title":"Eur J Heart Fail"},{"key":"3105_CR11","doi-asserted-by":"crossref","unstructured":"Soghomonian A, Dutour A, Kachenoura N, Thuny F, Lasbleiz A, Ancel P et al. Is increased myocardial triglyceride content associated with early changes in left ventricular function? A 1H-MRS and MRI strain study. Front Endocrinol (Lausanne). 2023;14.","DOI":"10.3389\/fendo.2023.1181452"},{"issue":"14","key":"3105_CR12","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1096\/fj.04-2263com","volume":"18","author":"S Sharma","year":"2004","unstructured":"Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K, et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J. 2004;18(14):1692\u2013700.","journal-title":"FASEB J"},{"issue":"1","key":"3105_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2337\/db15-0627","volume":"65","author":"E Levelt","year":"2016","unstructured":"Levelt E, Mahmod M, Piechnik SK, Ariga R, Francis JM, Rodgers CT, et al. Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes. Diabetes. 2016;65(1):44\u201352.","journal-title":"Diabetes"},{"issue":"8","key":"3105_CR14","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1210\/jc.2015-1139","volume":"100","author":"R Muniyappa","year":"2015","unstructured":"Muniyappa R, Noureldin R, Ouwerkerk R, Liu EY, Madan R, Abel BS, et al. Myocardial fat accumulation is independent of measures of insulin sensitivity. J Clin Endocrinol Metab. 2015;100(8):3060\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3105_CR15","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1210\/jc.2012-3190","volume":"98","author":"M Gran\u00e9r","year":"2013","unstructured":"Gran\u00e9r M, Siren R, Nyman K, Lundbom J, Hakkarainen A, Pentik\u00e4inen MO, et al. Cardiac steatosis associates with visceral obesity in nondiabetic obese men. J Clin Endocrinol Metab. 2013;98(3):1189\u201397.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"3105_CR16","doi-asserted-by":"publisher","first-page":"E935","DOI":"10.1152\/ajpendo.00095.2005","volume":"289","author":"JS Reingold","year":"2005","unstructured":"Reingold JS, McGavock JM, Kaka S, Tillery T, Victor RG, Szczepaniak LS. Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method. Am J Physiology-Endocrinology Metabolism. 2005;289(5):E935\u20139.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"3105_CR17","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/mrm.10372","volume":"49","author":"LS Szczepaniak","year":"2003","unstructured":"Szczepaniak LS, Dobbins RL, Metzger GJ, Sartoni-D\u2019Ambrosia G, Arbique D, Vongpatanasin W, et al. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med. 2003;49(3):417\u201323.","journal-title":"Magn Reson Med"},{"issue":"5","key":"3105_CR18","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2310\/6650.2007.00003","volume":"55","author":"I Zib","year":"2007","unstructured":"Zib I, Jacob AN, Lingvay I, Salinas K, McGavock JM, Raskin P, et al. Effect of Pioglitazone therapy on myocardial and hepatic steatosis in Insulin-Treated patients with type 2 diabetes. J Investig Med. 2007;55(5):230\u20136.","journal-title":"J Investig Med"},{"issue":"15","key":"3105_CR19","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1161\/CIRCULATIONAHA.108.803916","volume":"119","author":"RW van der Meer","year":"2009","unstructured":"van der Meer RW, Rijzewijk LJ, de Jong HWAM, Lamb HJ, Lubberink M, Romijn JA, et al. Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus. Circulation. 2009;119(15):2069\u201377.","journal-title":"Circulation"},{"issue":"1","key":"3105_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12933-021-01237-2","volume":"20","author":"B Gaborit","year":"2021","unstructured":"Gaborit B, Ancel P, Abdullah AE, Maurice F, Abdesselam I, Calen A, et al. Effect of empagliflozin on ectopic fat stores and myocardial energetics in type 2 diabetes: the EMPACEF study. Cardiovasc Diabetol. 2021;20(1):57.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3105_CR21","doi-asserted-by":"publisher","first-page":"15348","DOI":"10.1038\/s41598-019-51949-5","volume":"9","author":"JC Hsu","year":"2019","unstructured":"Hsu JC, Wang CY, Su MYM, Lin LY, Yang WS. Effect of empagliflozin on cardiac function, adiposity, and diffuse fibrosis in patients with type 2 diabetes mellitus. Sci Rep. 2019;9(1):15348.","journal-title":"Sci Rep"},{"issue":"12","key":"3105_CR22","doi-asserted-by":"publisher","first-page":"e50077","DOI":"10.1371\/journal.pone.0050077","volume":"7","author":"D Jankovic","year":"2012","unstructured":"Jankovic D, Winhofer Y, Promintzer-Schifferl M, Wohlschl\u00e4ger-Krenn E, Anderwald CH, Wolf P, et al. Effects of insulin therapy on myocardial lipid content and cardiac geometry in patients with type-2 diabetes mellitus. PLoS ONE. 2012;7(12):e50077.","journal-title":"PLoS ONE"},{"issue":"11","key":"3105_CR23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/eci.12817","volume":"47","author":"L Kosi-Trebotic","year":"2017","unstructured":"Kosi-Trebotic L, Thomas A, Harreiter J, Chmelik M, Trattnig S, Kautzky\u2010Willer A. Gliptin therapy reduces hepatic and myocardial fat in type 2 diabetic patients. Eur J Clin Invest. 2017;47(11):829\u201338.","journal-title":"Eur J Clin Invest"},{"key":"3105_CR24","doi-asserted-by":"crossref","unstructured":"Leung M, Wong VW, Hudson M, Leung DY. Impact of improved glycemic control on cardiac function in type 2 diabetes mellitus. Circ Cardiovasc Imaging. 2016;9(3).","DOI":"10.1161\/CIRCIMAGING.115.003643"},{"issue":"10","key":"3105_CR25","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cjco.2023.06.007","volume":"5","author":"SJ Lavine","year":"2023","unstructured":"Lavine SJ, Prcevski P. The effect of glycemic control on left ventricular function in clinical and experimental diabetes. CJC Open. 2023;5(10):728\u201338.","journal-title":"CJC Open"},{"issue":"3","key":"3105_CR26","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3390\/jcm14030862","volume":"14","author":"J Rives","year":"2025","unstructured":"Rives J, Gil-Millan P, Vilad\u00e9s D, Garc\u00eda-Osuna \u00c1, Genua I, Mi\u00f1ambres I, et al. Low-Density lipoprotein subfraction phenotype is associated with epicardial adipose tissue volume in type 2 diabetes. J Clin Med. 2025;14(3):862.","journal-title":"J Clin Med"},{"issue":"13","key":"3105_CR27","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.3390\/jcm14134687","volume":"14","author":"P Gil-Millan","year":"2025","unstructured":"Gil-Millan P, Rives J, Vilad\u00e9s D, Garc\u00eda-Osuna \u00c1, Genua I, Mi\u00f1ambres I, et al. Association of epicardial adipose tissue with novel inflammation and heart failure biomarkers in type 2 diabetes patients: effect of metabolic control. J Clin Med. 2025;14(13):4687.","journal-title":"J Clin Med"},{"issue":"Supplement1","key":"3105_CR28","first-page":"S13","volume":"41","author":"2. Classification and Diagnosis of Diabetes","year":"2018","unstructured":"2. Classification and Diagnosis of Diabetes. Standards of medical care in Diabetes\u20142018. Diabetes Care. 2018;41(Supplement1):S13\u201327.","journal-title":"Diabetes Care"},{"issue":"33","key":"3105_CR29","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J"},{"issue":"39","key":"3105_CR30","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G, Wiklund O, John Chapman M, Drexel H, et al. 2016 ESC\/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37(39):2999\u20133058.","journal-title":"Eur Heart J"},{"issue":"7","key":"3105_CR31","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MG, Hern\u00e1ndez-Gonz\u00e1lez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"47","key":"3105_CR32","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","volume":"42","author":"HN Ginsberg","year":"2021","unstructured":"Ginsberg HN, Packard CJ, Chapman MJ, Bor\u00e9n J, Aguilar-Salinas CA, Averna M, et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies\u2014a consensus statement from the European atherosclerosis society. Eur Heart J. 2021;42(47):4791\u2013806.","journal-title":"Eur Heart J"},{"issue":"12","key":"3105_CR33","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/ehjci\/jez232","volume":"20","author":"SE Petersen","year":"2019","unstructured":"Petersen SE, Khanji MY, Plein S, Lancellotti P, Bucciarelli-Ducci C. European association of cardiovascular imaging expert consensus paper: a comprehensive review of cardiovascular magnetic resonance normal values of cardiac chamber size and aortic root in adults and recommendations for grading severity. Eur Heart J Cardiovasc Imaging. 2019;20(12):1321\u201331.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"3105_CR34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1148\/radiol.2451061904","volume":"245","author":"RW van der Meer","year":"2007","unstructured":"van der Meer RW, Doornbos J, Kozerke S, Sch\u00e4r M, Bax JJ, Hammer MS, et al. Metabolic imaging of myocardial triglyceride content: reproducibility of 1 H MR spectroscopy with respiratory navigator gating in volunteers. Radiology. 2007;245(1):251\u20137.","journal-title":"Radiology"},{"issue":"5","key":"3105_CR35","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/jmri.25254","volume":"44","author":"P de Heer","year":"2016","unstructured":"de Heer P, Bizino MB, Lamb HJ, Webb AG. Parameter optimization for reproducible cardiac 1 H-MR spectroscopy at 3 Tesla. J Magn Reson Imaging. 2016;44(5):1151\u20138.","journal-title":"J Magn Reson Imaging"},{"key":"3105_CR36","unstructured":"The Jamovi Project. (2022). jamovi (Version 2.5) [Computer Software]. Retrieved from https:\/\/www.jamovi.org"},{"issue":"7","key":"3105_CR37","doi-asserted-by":"publisher","first-page":"103860","DOI":"10.1016\/j.numecd.2025.103860","volume":"35","author":"PR Roos","year":"2025","unstructured":"Roos PR, van den Burg EL, Schoonakker MP, van Peet PG, Numans ME, Pijl H, et al. Fasting-mimicking diet in type 2 diabetes reduces myocardial triglyceride content: a 12-month randomised controlled trial. Nutr Metabolism Cardiovasc Dis. 2025;35(7):103860.","journal-title":"Nutr Metabolism Cardiovasc Dis"},{"issue":"1","key":"3105_CR38","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12933-024-02243-w","volume":"23","author":"K Shi","year":"2024","unstructured":"Shi K, Zhang G, Fu H, Li XM, Gao Y, Shi R, et al. Glycemic control and clinical outcomes in diabetic patients with heart failure and reduced ejection fraction: insight from ventricular remodeling using cardiac MRI. Cardiovasc Diabetol. 2024;23(1):148.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"3105_CR39","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s00125-011-2146-0","volume":"54","author":"M Kr\u0161\u0161\u00e1k","year":"2011","unstructured":"Kr\u0161\u0161\u00e1k M, Winhofer Y, G\u00f6bl C, Bischof M, Reiter G, Kautzky-Willer A, et al. Insulin resistance is not associated with myocardial steatosis in women. Diabetologia. 2011;54(7):1871\u20138.","journal-title":"Diabetologia"},{"issue":"10","key":"3105_CR40","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1161\/CIRCULATIONAHA.114.014796","volume":"132","author":"MA Cavender","year":"2015","unstructured":"Cavender MA, Steg PG, Smith SC, Eagle K, Ohman EM, Goto S, et al. Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death. Circulation. 2015;132(10):923\u201331.","journal-title":"Circulation"},{"issue":"2","key":"3105_CR41","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1161\/CIRCHEARTFAILURE.113.000920","volume":"8","author":"HM Parry","year":"2015","unstructured":"Parry HM, Deshmukh H, Levin D, Van Zuydam N, Elder DHJ, Morris AD, et al. Both high and low HbA1c predict incident heart failure in type 2 diabetes mellitus. Circ Heart Fail. 2015;8(2):236\u201342.","journal-title":"Circ Heart Fail"},{"issue":"12","key":"3105_CR42","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1136\/hrt.2003.020842","volume":"90","author":"H von Bibra","year":"2004","unstructured":"von Bibra H. Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes. Heart. 2004;90(12):1483\u20134.","journal-title":"Heart"},{"issue":"1","key":"3105_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/eurjhf\/hfn018","volume":"11","author":"C Jarnert","year":"2009","unstructured":"Jarnert C, Landstedt-Hallin L, Malmberg K, Melcher A, Ohrvik J, Persson H, et al. A randomized trial of the impact of strict glycaemic control on myocardial diastolic function and perfusion reserve: a report from the DADD (diabetes mellitus and diastolic dysfunction) study. Eur J Heart Fail. 2009;11(1):39\u201347.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"3105_CR44","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/BF00569568","volume":"32","author":"SCL Gough","year":"1995","unstructured":"Gough SCL, Smyllie J, Barker M, Berkin KE, Rice PJS, Grant PJ. Diastolic dysfunction is not related to changes in glycaemic control over 6 months in type 2 (non-insulin-dependent) diabetes mellitus. Acta Diabetol. 1995;32(2):110\u20135.","journal-title":"Acta Diabetol"},{"key":"3105_CR45","doi-asserted-by":"publisher","first-page":"106243","DOI":"10.1016\/j.phrs.2022.106243","volume":"180","author":"P Theofilis","year":"2022","unstructured":"Theofilis P, Antonopoulos AS, Katsimichas T, Oikonomou E, Siasos G, Aggeli C, et al. The impact of SGLT2 Inhibition on imaging markers of cardiac function: a systematic review and meta-analysis. Pharmacol Res. 2022;180:106243.","journal-title":"Pharmacol Res"},{"issue":"6","key":"3105_CR46","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1002\/ehf2.13645","volume":"8","author":"NK Dhingra","year":"2021","unstructured":"Dhingra NK, Mistry N, Puar P, Verma R, Anker S, Mazer CD, et al. SGLT2 inhibitors and cardiac remodelling: a systematic review and meta-analysis of randomized cardiac magnetic resonance imaging trials. ESC Heart Fail. 2021;8(6):4693\u2013700.","journal-title":"ESC Heart Fail"},{"issue":"8","key":"3105_CR47","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/ejhf.2884","volume":"25","author":"DA Pascual-Figal","year":"2023","unstructured":"Pascual-Figal DA, Zamorano JL, Domingo M, Morillas H, Nu\u00f1ez J, Cobo Marcos M, et al. Impact of Dapagliflozin on cardiac remodelling in patients with chronic heart failure: the DAPA\u2010MODA study. Eur J Heart Fail. 2023;25(8):1352\u201360.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"3105_CR48","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s40119-022-00260-y","volume":"11","author":"BY Sayin","year":"2022","unstructured":"Sayin BY, Oto A. Left ventricular hypertrophy: Etiology-Based therapeutic options. Cardiol Ther. 2022;11(2):203\u201330.","journal-title":"Cardiol Ther"},{"issue":"16","key":"3105_CR49","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.jacc.2025.06.055","volume":"86","author":"M Packer","year":"2025","unstructured":"Packer M. The adipokine hypothesis of heart failure with a preserved ejection fraction. J Am Coll Cardiol. 2025;86(16):1269\u2013373.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"3105_CR50","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1148\/radiol.2021210188","volume":"301","author":"J He","year":"2021","unstructured":"He J, Yang W, Wu W, Li S, Yin G, Zhuang B, et al. Early diastolic longitudinal strain rate at MRI and outcomes in heart failure with preserved ejection fraction. Radiology. 2021;301(3):582\u201392.","journal-title":"Radiology"},{"issue":"2","key":"3105_CR51","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ehf2.12260","volume":"5","author":"F Hohendanner","year":"2018","unstructured":"Hohendanner F, Messroghli D, Bode D, Blaschke F, Parwani A, Boldt L, et al. Atrial remodelling in heart failure: recent developments and relevance for heart failure with preserved ejection fraction. ESC Heart Fail. 2018;5(2):211\u201321.","journal-title":"ESC Heart Fail"},{"issue":"19","key":"3105_CR52","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1001\/jama.2013.280521","volume":"310","author":"HS Abed","year":"2013","unstructured":"Abed HS, Wittert GA, Leong DP, Shirazi MG, Bahrami B, Middeldorp ME, et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation. JAMA. 2013;310(19):2050.","journal-title":"JAMA"},{"issue":"10","key":"3105_CR53","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/echo.13306","volume":"33","author":"I Byty\u00e7i","year":"2016","unstructured":"Byty\u00e7i I, Bajraktari G. Left atrial changes in early stages of heart failure with preserved ejection fraction. Echocardiography. 2016;33(10):1479\u201387.","journal-title":"Echocardiography"},{"key":"3105_CR54","doi-asserted-by":"crossref","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American college of Cardiology\/American heart association joint committee on clinical practice guidelines. Circulation. 2022;145(18).","DOI":"10.1161\/CIR.0000000000001073"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03105-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03105-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03105-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T12:02:36Z","timestamp":1775131356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03105-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3105"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03105-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8097719\/v1","asserted-by":"object"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by our local Ethics Committee of the Hospital de SANT PAU (IIBSP-REL-2017-27; date: Jul 26, 2017); all the procedures fully complied with the Declaration of Helsinki. All the subjects provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}